T. Hidaka

发表

Environmental pollutants and the immune response

Takafumi Suzuki, Masayuki Yamamoto, T. Hidaka, 2020, Nature Immunology.

Successful treatment of HER-2-positive metastatic apocrine carcinoma of the skin with lapatinib and capecitabine.

M. Mizuashi, S. Aiba, T. Fujimura, 2012, Acta dermato-venereologica.

Plasminogen Activating Inhibitor-1 Might Predict the Efficacy of Anti-PD1 Antibody in Advanced Melanoma Patients

T. Fujimura, Y. Kambayashi, K. Ohuchi, 2021, Frontiers in Oncology.

Tumor-Associated Macrophages: Therapeutic Targets for Skin Cancer

Y. Fujisawa, S. Aiba, T. Fujimura, 2018, Front. Oncol..

The Expression of Matrix Metalloproteinases in Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL)-expressing Cancer of Apocrine Origin.

S. Aiba, T. Fujimura, Y. Kambayashi, 2018, Anticancer research.

Immunomodulatory Effect of Imiquimod Through CCL22 Produced by Tumor-associated Macrophages in B16F10 Melanomas.

S. Aiba, T. Fujimura, Y. Kambayashi, 2017, Anticancer research.

A synthetic NOD2 agonist, muramyl dipeptide (MDP)-Lys (L18) and IFN-β synergistically induce dendritic cell maturation with augmented IL-12 production and suppress melanoma growth.

Yumiko Ito, S. Aiba, T. Fujimura, 2011, Journal of dermatological science.

Tumor-associated M2 macrophages in mycosis fungoides acquire immunomodulatory function by interferon alpha and interferon gamma.

S. Aiba, T. Fujimura, T. Hidaka, 2016, Journal of dermatological science.

Comparison of Foxp3+ regulatory T cells and CD163+ macrophages in invasive and non-invasive extramammary Paget's disease.

S. Aiba, T. Fujimura, Y. Kambayashi, 2012, Acta dermato-venereologica.

Possible Roles of Proinflammatory Signaling in Keratinocytes Through Aryl Hydrocarbon Receptor Ligands for the Development of Squamous Cell Carcinoma

Masayuki Yamamoto, S. Aiba, S. Matsushita, 2020, Frontiers in Immunology.

A Novel Missense Mutation of DKC1 In Dyskeratosis Congenita With Pulmonary Fibrosis.

H. Kanegane, M. Ebina, T. Hidaka, 2013, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.

Successful treatment of pigmented dermatofibrosarcoma protuberance on the nasal root with cyberknife radiosurgery.

S. Aiba, T. Fujimura, A. Hashimoto, 2012, Acta dermato-venereologica.

Successful Treatment of MMP-9-Expressing Angiosarcoma with Low-Dose Docetaxel and Bisphosphonate

S. Aiba, T. Fujimura, Y. Kambayashi, 2012, Case Reports in Dermatology.

HLA‐DRB1*04:05 in two cases of Vogt–Koyanagi–Harada disease‐like uveitis developing from an advanced melanoma patient treated by sequential administration of nivolumab and dabrafenib/trametinib therapy

S. Aiba, T. Fujimura, Y. Kambayashi, 2018, The Journal of dermatology.

GITR cosignal in ILC2s controls allergic lung inflammation.

C. Riccardi, T. So, T. Fujita, 2018, The Journal of allergy and clinical immunology.

Successful Treatment of Unresectable Advanced Melanoma by Administration of Nivolumab With Ipilimumab Before Primary Tumor Resection

S. Aiba, T. Fujimura, Y. Kambayashi, 2019, Front. Med..

Malassezia‐derived aryl hydrocarbon receptor ligands enhance the CCL20/Th17/soluble CD163 pathogenic axis in extra‐mammary Paget's disease

Y. Fujisawa, S. Aiba, A. Otsuka, 2019, Experimental dermatology.

The aryl hydrocarbon receptor AhR links atopic dermatitis and air pollution via induction of the neurotrophic factor artemin

K. Nakayama, Takafumi Suzuki, Masayuki Yamamoto, 2016, Nature Immunology.

Serum levels of soluble CD163 and CXCL5 may be predictive markers for immune-related adverse events in patients with advanced melanoma treated with nivolumab: a pilot study

Y. Fujisawa, S. Aiba, H. Uchi, 2018, Oncotarget.

Aryl Hydrocarbon Receptor Modulates Carcinogenesis and Maintenance of Skin Cancers

S. Aiba, T. Fujimura, T. Hidaka, 2019, Front. Med..

Serum Level of Soluble CD163 May Be a Predictive Marker of the Effectiveness of Nivolumab in Patients With Advanced Cutaneous Melanoma

Y. Fujisawa, S. Aiba, H. Uchi, 2018, Front. Oncol..

Receptor activator of nuclear factor kappa‐B ligand (RANKL)/RANK signaling promotes cancer‐related inflammation through M2 macrophages

S. Aiba, T. Fujimura, Y. Kambayashi, 2016, Experimental dermatology.

Chronicity of Immune Abnormality in Atopic Dermatitis: Interacting Surface Between Environment and Immune System

Masayuki Yamamoto, T. Hidaka, E. Kobayashi, 2016 .

Biomarkers for Predicting Efficacies of Anti-PD1 Antibodies

S. Aiba, T. Fujimura, Y. Kambayashi, 2019, Front. Med..

BRAF kinase inhibitors for treatment of melanoma: developments from early-stage animal studies to Phase II clinical trials

S. Aiba, T. Fujimura, Y. Kambayashi, 2018, Expert opinion on investigational drugs.

Successful treatment of relapsed folliculotropic mycosis fungoides with mogamulizumab followed by intensity‐modulated radiotherapy

S. Aiba, T. Fujimura, Y. Kambayashi, 2018, Journal of dermatology (Print).

Severe erythema exudative multiforme developing from advanced melanoma treated with dabrafenib and trametinib followed by nivolumab

M. Mizuashi, S. Aiba, T. Fujimura, 2018, The Journal of dermatology.

Successful treatment of multiple in‐transit melanomas on the leg with intensity‐modulated radiotherapy and immune checkpoint inhibitors: Report of two cases

S. Aiba, T. Fujimura, Y. Kambayashi, 2017, The Journal of dermatology.

Phase I study of nivolumab combined with IFN-β for patients with advanced melanoma

S. Aiba, Takuhiro Yamaguchi, R. Morimoto, 2017, Oncotarget.

Isolated adrenocorticotropic hormone deficiency possibly caused by nivolumab in a metastatic melanoma patient

S. Aiba, R. Morimoto, T. Fujimura, 2017, The Journal of dermatology.

Successful Treatment of Advanced Primary Cutaneous Apocrine Carcinoma on the Scrotum with Systemic Chemotherapy and Radiotherapy Followed by Denosumab

S. Aiba, T. Fujimura, Y. Kambayashi, 2017, Case Reports in Oncology.

Possible mechanisms of the crosstalk between Langerhans cells and regulatory T cells in extramammary Paget disease by receptor activator of nuclear factor kappa B (RANK) ligand/RANK pathways

S. Aiba, T. Fujimura, Y. Kambayashi, 2017, The British journal of dermatology.

Sequential Therapy with Nivolumab Followed by Ipilimumab Induces Complete Response in Metastatic Melanoma of the Lung but with Severe Hepatotoxicities

S. Aiba, T. Fujimura, Y. Kambayashi, 2016, Case Reports in Oncology.

Recurrent Multiple Squamous Cell Carcinomas on the Scalp in a Patient with Juvenile Dermatomyositis

S. Aiba, T. Fujimura, Y. Kambayashi, 2017, Case Reports in Oncology.

Successful Treatment of Primary Cutaneous Peripheral T-Cell Lymphoma Presenting Acquired Ichthyosis with Oral Bexarotene Monotherapy

S. Aiba, T. Fujimura, Y. Kambayashi, 2017, Case Reports in Oncology.